Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Slavic Svetlana,

Beiträge für wissenschaftliche Veranstaltungen

Vortrag

Andrukhova, O; Latic, N; Radloff, J; Slavic, S; Endler, L; Murali, S; Bayer, J; Zeitz, U; Pfeiffenberger, U; Tangermann, S; Lagger, S; Wilflingseder, J; Kenner, L; Strobl, B; Erben, R [and 3 others] (2019): FGF23 Promotes Disease Progression in 5/6-Nephrectomized Mice By WNK and Proinflammatory Signaling. Annual Meeting of the American-Society-for-Bone-and Mineral Research, Orlando, FL, United States, SEP 20-23, 2019. J Bone Miner Res (34), S1 57-58.

Andrukhova, O; Latic, N; Radloff, J; Slavic, S; Endler, L; Murali, SK; Bayer, J; Zeitz, U; Pfeiffenberger, U; Kornauth, C; Tangermann, S; Lagger, S; Wilflingseder, J; Kenner, L; Alessi, DR [and 3 others] (2019): FGF23 Promotes Disease Progression in 5/6-Nephrectomized Mice By WNK and Proinflammatory Signaling. -ASBMR Annual Meeting; 20.-23.09.2019; Orlando, FL, United States (USA).

Godoy, JR; Pittrich, S; Slavic, S; Hanschmann, EM; Lillig, CH; Erben, R (2017): Expression of Redox Proteins in the Heart After Myocardial Infarction in Rats. 24th Annual Meeting of the Society-for-Redox-Biology-and-Medicine (SfRBM), Baltimore, MD, United States, NOV 29-DEC 02, 2017. Free Radical Bio Med (112), S1 112-112.

Andrukhova, O; Slavic, S; Bayer, J; Erben, RG (2016): Genetic or Pharmacological Ablation of Fgf23 Ameliorates Progression of Chronic Kidney Disease in Mice. DVG Tagung; 30 March-1 April, 2016; Berlin, Germany. 2016.

Ford, K; Slavic, S; Zeitz, U; Dolezal, M; Erben, RG; Andrukhova, O (2016): Lack Of Fibroblast Growth Factor-23 (FGF23) Preserves Cardiac Function In A Murine Model Of Acute Myocardial Infarction. Annual Conference of the British-Cardiovascular-Society (BCS) on Prediction and Prevention, Manchester, ENGLAND, United Kingdom, JUN 06-08, 2016. Heart (102) A131-A131.

Slavic, S; Andrukhova, O; Zeitz, U; Ford, K; Kleiter, M; Handschuh, S; Kostenuik, PJ; Erben, RG (2016): Selective Inhibition of Receptor Activator of NF-KB Ligand (RANKL) In Hematopoietic Cells improves Outcome after Experimental Myocardial Infarction in Mice. DVG-Fachgruppentagung Physiologie und Biochemie ; MAR 30 - APR 1, 2016; Berlin, DEUTSCHLAND. 2016.

Slavic, S; Ford, K; Zeitz, U; Erben, R; Andrukhova, O (2016): Genetic Ablation of Fgf23 Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload. ASBMR 2016 ; SEP 16-19, 2016; Atlanta, USA. 2016.

Andrukhova, O; Slavic, S; Murali, SK; Richards, WG; Erben, RG (2015): FGF23 ameliorates progression of chronic kidney disease in a Klotho-independent Fashion. -ASBMR Conference; SEP 12-15, 2015; Seattle WA, US.

Andrukhova, O; Slavic, S; Murali, SK; Richards, WG; Erben, RG (2015): Genetic or Pharmacological Ablation of Fgf23 Ameliorates Progression of Chronic Kidney Disease in Mice. -ASN Conference (Kidney week 2015); NOV 4-8, 2015; San Diego, CA, US.

Slavic, S; Andrukhova, O; Zeitz, U; Ford, K; Kleiter, M; Handschuh, S; Kostenuik, PJ; Erben, RG (2015): Selective inhibition of receptor activator of NFkB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction in mice. Congress of the European-Society-of-Cardiology (ESC), London, ENGLAND, United Kingdom, AUG 29-SEP 02, 2015. Eur Heart J (36) 584-584.

Lauer, D; Slavic, S; Sommerfeld, M; Thone-Reineke, C; Sharkovska, Y; Hallberg, A; Dahlof, B; Kintscher, U; Unger, T; Steckelings, UM; Kaschina, E; Kaschina, E (2013): AT2 Receptor Agonism Regulates TIMP1/MMP9 Axis in the Heart Preventing Cardiac Fibrosis and Improving Heart Function After Experimental Myocardial Infarction. American-Heart-Association High Blood Pressure Research Scientific Sessions, New Orleans, LA, SEP 11-14, 2013. Hypertension (62), 3 Abstract 58.

Andrukhova, O; Slavic, S; Zeitz, U; Goetz, R; Shalhoub, V; Mohammadi, M; Lanske, B; Erben, RG (2012): FGF23 regulates renal sodium handling and blood pressure. International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor, Vienna, AUSTRIA, Austria, NOV 29 - DEC 01, 2012. Bone (51), 6 S4-S4.

Andrukhova, O; Slavic, S; Zeitz, U; Goetz, R; Shalhoub, V; Mohammadi, M; Lanske, B; Erben, RG (2012): FGF23 Regulates Renal Sodium Handling and Blood Pressure. -American Society of Nephrology Annual Meeting; Oct 31- Nov 4, 2012; San Diego, USA.

Andrukhova; O; Slavic, S; Zeitz, U; Goetz, R; Shalhoub, V; Mohammadi, M; Lanske, B; Erben, RG (2012): FGF23 Regulates Renal Sodium Handling and Blood Pressure. -Int. Conference on Progress in Bone and Mineral Research; Oct. 30 - Nov. 4, 2012; Vienna, Austria.

Poster

Ford, K; Slavic, S; Klinger, F; Dolezal, M; Zeitz, U; Hilse, K; Pohl; E; Erben, RG; Andrukhova, O (2017): Lack of Fibroblast Growth Factor-23 (FGF-23) Improves Cardiac Function in a Murine Model of Acute Myocardial Infarction. American Society for Bone and Mineral Research 2017 Annual Meeting; SEP 08-11, 2017; Denver, CO, United States (USA). 2017.

Ford, K; Slavic, S; Klinger, F; Klinger, F; Dolezal, M; Zeitz, U; Hilse-Koller, K; Pohl, E; Erben, RG; Andrukhova, O (2017): Lack of Fibroblast Growth Factor-23 (Fgf23) signaling improves cardiac function in a murine model of acute myocardial infarction. Annual Meeting of the American-Society-for-Bone-and-Mineral-Research (ASBMR), Denver, CO, United States, SEP 08-11, 2017. J Bone Miner Res (32), S1 S73-S73.

Andrukhova, O; Slavic, S; Bayer, J; Richards, WG; Alessi, CD; Erben, RG (2016): Excessive Fgf23 Drives Progression of Chronic Kidney Disease in Mice Via Partially Klotho-Independent Activation of WNK Signaling. ASN Kidney Week; 16-20 Nov, 2016; Chicago, Illinois, USA. 2016.

Andrukhova, O; Slavic, S; Ford, K; Bayer, J; Murali, SK; Erben, RG (2015): Circulating FGF23 is elevated in acute myocardial infarction. -ECTS Annual Meeting ; APR 24-28, 2015; Rotterdam, The Netherlands.

Andrukhova, O; Slavic, S; Ford, K; Bayer, J; Murali, SK; Erben, RG (2015): Circulating FGF23 is elevated in acute myocardial infarction. -Annual Vitamin D Conference; APR 21-24, 2015; Delft, Netherlands .

Slavic, S; Odörfer, K; Godoy, J; Zeitz, U; Erben, RG (2015): Experimental myocardial infarction does not induce osteopenia. -European Calcified Tissue Society and the International Bone and Mineral Society (ECTS-IBMS 2015); Apr 2015; Rotterdam, The Netherlands.

Andrukhova, O; Lavic, S; Murali, SK; Erben, RG (2014): FGF23 but not Klotho deficiency ameliorates progression of chronic kidney disease in mice. -ASN conference (Kidney week); Nov 11-16, 2014; Philadelphia, USA.

Andrukhova, O; Slavic, S; Murali, SK; Erben, RG (2014): FGF23 deficiency ameliorates progression of chronic kidney disease in mice. -ASBMR Annual Meeting; Sep 12-15, 2014; Houston, USA.

Slavic, S; Andrukhova, O; Zeitz, U; Riesen, SC; Ambrisko, TD; Markovic, M; Kuebler, WM; Erben, RG (2014): Vitamin D Is A Regulator Of Endothelial Nitric Oxide Synthase And Arterial Stiffness In Mice. -World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases ; Apr 2-5, 2014; Sevilla, Spain.

Slavic, S; Andrukhova, O; Zeitz, U; Riesen, SC; Ambrisko, TD; Markovic, M; Kuebler, WM; Erben, RG (2014): Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Seville, SPAIN, Spain, APR 02-05, 2014. Osteoporosis Int (25), S2 S436-S437.

Andrukhova, O; Slavic, S; Zeitz, U; Riesen, S; Ambrisko, T; Markovic, M; Kuebler, W; Erben, R (2013): Vitamin D Is a Regulator of Endothelial Nitric Oxide Synthase and Arterial Stiffness in Mice. Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, Baltimore, MD, OCT 04-07, 2013. J Bone Miner Res (28), S1

Lauer, D; Slavic, S; Sommerfeld, M; Unger, T; Steckelings, UM; Kaschina, E (2013): AT2 receptor agonism improves cardiac function, prevents remodeling and reduces proteolytic activity of MMP9 in the heart after experimental myocardial infarction. Heart Failure Congress 2013, Lisbon, Portugal, Portugal, MAY 25-28, 2013. Eur J Heart Fail (12), S1 S39-S39.

Odoerfer, K; Slavic, S; Proell, V; Spielberger, V; Markovic, M; Kleiter, M; Erben, RG (2012): Anti-inflammatory effect of intravenously administered bone marrow cells in a rat model of myocardial infarction. -ESC - Heart Failure; May 18-22, 2012; Belgrad, Serbia.

Slavic, S; Kemnitz, R; Paulis, L; Baulmann, J; Unger, T; Kaschina, E (2012): Inhibition of cannabinoid receptor-1 reduces arterial stiffness in the rat model of heart failure. -ESC - Heart Failure; May 18 -22, 2012; Belgrad, Serbia.

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit